Advanced metastatic triple-negative breast cancer (MTNBC)

Clinical trials for Advanced metastatic triple-negative breast cancer (MTNBC) explained in plain language.

Never miss a new study

Get alerted when new Advanced metastatic triple-negative breast cancer (MTNBC) trials appear

Sign up with your email to follow new studies for Advanced metastatic triple-negative breast cancer (MTNBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Radioactive injection targets Hard-to-Treat breast cancer in early trial

Disease control Recruiting now

This early-phase trial is testing a radioactive drug called 225Ac-TR2205 in 15 women with advanced triple-negative breast cancer that has spread. The main goal is to see if the drug is safe and tolerable, and to measure how much radiation reaches tumors. It is too early to know i…

Matched conditions: ADVANCED METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)

Early phase 1 • Sponsor: Xiaorong Sun • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

Advanced metastatic triple-negative breast cancer (MTNBC)

Get alerted when new Advanced metastatic triple-negative breast cancer (MTNBC) trials appear

Radioactive injection targets Hard-to-Treat breast cancer in early trial